XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY Statement - USD ($)
shares in Millions
Total
Operating Expense [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Stock [Member]
Stockholders Equity [Line Items]              
Shares, Issued     (137.1)       (61.5)
Total stockholders’ equity $ 414,000,000   $ 1,000,000 $ 6,771,000,000 $ (1,091,000,000) $ (133,000,000) $ (5,134,000,000)
Net income (loss) (29,000,000)            
Other Comprehensive Income (Loss), Net of Tax (7,000,000)            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 9,000,000     (27,000,000)     $ 36,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period             0.3
Stock Issued During Period, Value, Stock Options Exercised       (5,000,000)     $ (5,000,000)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period             0.1
Comprehensive Income (Loss), Net of Tax, Attributable to Parent (36,000,000)            
Option Premiums Paid (16,000,000)     (16,000,000)      
Derivatives not designated as hedging instruments (1,000,000)            
Cumulative Effect of Accounting 5,000,000       4,000,000 1,000,000  
Shares, Issued     (137.1)       (61.1)
Total stockholders’ equity 324,000,000   $ 1,000,000 6,737,000,000 (1,178,000,000) (137,000,000) $ (5,099,000,000)
Net income (loss) 62,000,000            
Other Comprehensive Income (Loss), Net of Tax (2,000,000)            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 8,000,000     2,000,000     $ 6,000,000
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 60,000,000            
Option Premiums Paid (16,000,000)     (16,000,000)      
Derivatives not designated as hedging instruments (13,000,000) $ 5,000,000          
Shares, Issued     (137.1)       (61.1)
Total stockholders’ equity 376,000,000   $ 1,000,000 6,723,000,000 (1,116,000,000) (139,000,000) $ (5,093,000,000)
Shares, Issued     (137.1)       63.2
Total stockholders’ equity 656,000,000   $ 1,000,000 6,741,000,000 (785,000,000) (157,000,000) $ (5,144,000,000)
Net income (loss) (639,000,000)            
Other Comprehensive Income (Loss), Net of Tax (66,000,000)            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 3,000,000     (84,000,000)     $ 81,000,000
Stock Issued During Period, Value, Treasury Stock Reissued 15,000,000     15,000,000      
Stock Issued During Period, Shares, Treasury Stock Reissued             0.4
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period             0.4
Treasury Stock, Shares, Acquired             (5.0)
Treasury Stock, Value, Acquired, Cost Method (113,000,000)           $ 113,000,000
Comprehensive Income (Loss), Net of Tax, Attributable to Parent (705,000,000)            
Derivatives not designated as hedging instruments (10,000,000)            
Noncontrolling Interest, Increase from Sale of Parent Equity Interest (2,000,000)     (2,000,000)      
Cumulative Effect of Accounting (1,000,000)       (1,000,000)    
Shares, Issued     (137.1)       (67.5)
Total stockholders’ equity 292,000,000   $ 1,000,000 6,677,000,000 (944,000,000) (256,000,000) $ (5,186,000,000)
Net income (loss) (481,000,000)            
Other Comprehensive Income (Loss), Net of Tax 33,000,000            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 5,000,000     (5,000,000)     $ 10,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period             0.1
Comprehensive Income (Loss), Net of Tax, Attributable to Parent (448,000,000)            
Derivatives not designated as hedging instruments (28,000,000) $ (8,000,000)          
Noncontrolling Interest, Increase from Sale of Parent Equity Interest (2,000,000)     (2,000,000)      
Shares, Issued     (137.1)       (67.4)
Total stockholders’ equity $ (153,000,000)   $ 1,000,000 $ 6,670,000,000 $ (1,425,000,000) $ (223,000,000) $ (5,176,000,000)